2 registrations that name tulsi as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
Phase
All 2 registrations
RecruitingNCT07811310
Effect of Holy Basil on Subjects With Sensitive Skin
No phase
Laboratoires Expanscience S.A.
About 200 people
Started Aug 31, 2026
In plain words A study of tulsi in female participants 45 to 65, run by Laboratoires Expanscience S.A.. It plans to enroll about 200 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists female participants 45 to 65; healthy volunteers accepted. Conditions: Sensitive Skin Related to Stress.
Gender: Women
People aged between 45 and 65 years.
Presenting sensitive skin (Sensitive Scale 10 ≥ 20) with Tightness ≥ 4 and general malaise ≥ 4.
People who report being stressed (PSS10 questionnaire ≥ 14) and who report a relationship between skin sensitivity and psychological stress (according to the volunteer's opinion).
2 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Holy basil extract; Placebo
Registered summary
Stress can have multiple and varied psychological and clinical impacts on skin diseases (Colavincenzo and Granstein, 2006; Graubard et al., 2021). In particular, psychological stress has been shown to reduce the rebuilding kinetics of the skin barrier when altered and it is suggested that psychological stress may trigger or exacerbate immune-mediated dermatological disorders (Hall et al., 2012). Certain symptoms related to sensitive skin problems (itching, burning, pain, etc.) can lead to sleep disorders associated with stress and anxiety. The full summary is on the listing.
Where, as registered
No US site; Spain (1).
RecruitingNCT07175272
Holy Basil in The Treatment of Dyspepsia
Phase 2 and 3
Mahidol University
About 27 people
Started Feb 13, 2026
In plain words A Phase 2 and 3 study of tulsi in people 18 and older, run by Mahidol University. It plans to enroll about 27 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older. Conditions: Dyspepsia and Other Specified Disorders of Function of Stomach.
Participants aged 18 years and older.
Presence of dyspeptic symptoms, assessed by the Leeds Dyspepsia Questionnaire with a score of at least 5 or higher.
The exclusion criteria are on the listing.
What it tests, as registered
Holy basil extract
Registered summary
The goal of this clinical trial is to evaluate whether holy basil extract can reduce gastric inflammation and improve symptoms in adult patients with dyspepsia. The main questions it aims to answer are: * Does holy basil extract reduce gastric mucosal inflammation as measured by histopathology? * Does holy basil extract improve dyspeptic symptoms, endoscopic findings, gastric pH, duodenal eosinophil counts, and systemic inflammation (serum IL-6)? Participants will: * Take 300 mg of holy basil extract orally once daily for 28 days * Complete symptom questionnaires and diaries during treatment… The full summary is on the listing.